Data Collective IV’s Definium Therapeutics DFTX Stock Holding History

Data Collective IV’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.72M	Hold	100,350	–	–	6.01%	4
2026 Q1	$1.9M	Hold	100,350	–	–	3.39%	4
2025 Q4	$1.34M	Hold	100,350	–	–	2.3%	3
2025 Q3	$1.18M	Hold	100,350	–	–	1.74%	3
2025 Q2	$651K	Hold	100,350	–	–	0.5%	4
2025 Q1	$587K	Hold	100,350	–	–	0.68%	4
2024 Q4	$698K	Hold	100,350	–	–	0.31%	5
2024 Q3	$571K	Hold	100,350	–	–	0.35%	5
2024 Q2	$724K	Hold	100,350	–	–	0.51%	5
2024 Q1	$943K	Hold	100,350	–	–	0.82%	4
2023 Q4	$367K	Buy	100,350 +1	+0%	+$3	0.3%	4
2023 Q3	$314K	Sell	100,349 -1	-0%	-$4	0.3%	4
2023 Q2	$358K	Hold	100,350	–	–	0.27%	5
2023 Q1	$318K	Hold	100,350	–	–	0.34%	5
2022 Q4	$221K	Sell	100,350 -1,404,898	-93%	-$3.9M	0.23%	5
2022 Q3	$5.22M	Buy	1,505,248 +1,404,898	+1,400%	+$13.5M	4.13%	5
2022 Q2	$1.23M	Hold	100,350	–	–	1.02%	5
2022 Q1	$1.67M	Hold	100,350	–	–	0.35%	5
2021 Q4	$2.6M	Buy	+100,350	New	+$3.2M	0.35%	5

Other funds holding DFTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Data Collective IV's DFTX Position: Q2 2026 in Review

Data Collective IV held its Definium Therapeutics (DFTX) position steady in Q2 2026 at 100,350 shares worth $4.72M. The position accounts for 6.01% of the portfolio, ranked #4.

Data Collective IV first reported a position in DFTX in Q4 2021 and has held it in 19 quarters since. The position peaked at $5.22M in Q3 2022. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

Data Collective IV held 100,350 shares of Definium Therapeutics worth $4.72M as of Q2 2026.
Data Collective IV left its Definium Therapeutics share count unchanged in Q2 2026.
Definium Therapeutics made up 6.01% of Data Collective IV's portfolio in Q2 2026, its #4 holding.
Data Collective IV first reported a position in Definium Therapeutics in Q4 2021 and has held it in 19 quarters since.
Data Collective IV's Definium Therapeutics position peaked at $5.22M in Q3 2022.
362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Data Collective IV's 13F filing for Q2 2026, filed 14 Aug 2026.